WallStreetZenWallStreetZen

NASDAQ: LSB
Lakeshore Biopharma Co Ltd Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Lakeshore Biopharma Co earnings were -$238.4M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest LSB earnings report on Sep 30, 2024 announced Q3 2024 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2024 ending Mar 31, 2024, LSB reported annual earnings of -$433.5M, with 2.8% growth.

LSB earnings history

Current Revenue
$672.3M
Current Earnings
-$238.4M
Current Profit Margin
-35.5%

LSB Return on Equity

Current Company
-41.1%
Current Industry
19.9%
Current Market
35%
LSB's Return on Equity (-41.1%)... subscribe to Premium to read more.
High Return on Equity Performance

LSB undefined

Current Company
-15.7%
Current Industry
1.3%
LSB is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when LSB announces earnings.

LSB undefined

Current Company
-31.61%
Current Industry
14.3%

LSB vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
LSBN/A-$238.36MN/A-$21.59
DBVT-$114.79M-$113.92MN/A-$5.85
AVIR-$167.04M-$168.39MN/A-$2.00
CMPX-$47.62M-$49.38MN/A-$0.36
ABEO-$56.62M-$63.73MN/A-$1.55
View Top Biotech Stocks

Lakeshore Biopharma Co Earnings Reports & History FAQ

What were Lakeshore Biopharma Co's earnings last quarter?

Lakeshore Biopharma Co (NASDAQ: LSB) reported Q3 2024 earnings per share (EPS) of N/A, up N/A year over year. Total LSB earnings for the quarter were N/A. In the same quarter last year, Lakeshore Biopharma Co's earnings per share (EPS) was $5.62.

If you're new to stock investing, here's how to buy Lakeshore Biopharma Co stock.

Is Lakeshore Biopharma Co profitable or losing money?

As of the last Lakeshore Biopharma Co earnings report, Lakeshore Biopharma Co is currently losing money. Lakeshore Biopharma Co's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$238.36 million, a 36.4% decrease year over year.

What was LSB's earnings growth in the past year?

As of Lakeshore Biopharma Co's earnings date in Q2 2025, Lakeshore Biopharma Co's earnings has grown year over year. LSB earnings in the past year totalled -$238.36 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.